Kristen Cook
Nurse Practitioner · Albany, GANPI 1972156057
Payments from drug & device makers
Across 78 payments — averaging $27.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$334
- Regeneron Healthcare Solutions, Inc.$326
- Sanofi$279
- AbbVie$248
- Incyte Corporation$197
- Organon$120
- plus $652 from 16 others
What the payments were for
- Food & beverage$1,94390%
- Education$21210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 11 | $334 |
| Regeneron Healthcare Solutions, Inc. | 9 | $326 |
| Sanofi | 8 | $279 |
| AbbVie | 11 | $248 |
| Incyte Corporation | 10 | $197 |
| Organon | 1 | $120 |
| Vapotherm Inc | 1 | $99 |
| LEO Pharma Inc. | 4 | $80 |
| UCB, Inc. | 4 | $74 |
| Amgen | 4 | $74 |
| Merz North America, Inc. | 1 | $69 |
| Lilly USA, LLC | 3 | $64 |
| Pfizer | 2 | $40 |
| Biofrontera Inc. | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Almirall LLC | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Eisai Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,156 in reported general payments places this provider in the 85th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 13 | $16,565 |
| EliquisApixaban | 19 | $10,629 |
| Atorvastatin Calcium | 41 | $323 |
| Diclofenac Sodium | 12 | $228 |
| Levothyroxine Sodium | 13 | $203 |
| Torsemide | 15 | $192 |
| Fluticasone Propionate | 13 | $184 |
| Omeprazole | 17 | $179 |
| Losartan Potassium | 22 | $140 |
| Amlodipine Besylate | 19 | $115 |
| Metformin Hcl | 13 | $113 |
| Levocetirizine Dihydrochloride | 11 | $108 |
| Potassium Chloride | 12 | $71 |
| Ondansetron OdtOndansetron | 11 | $51 |
| Prednisone | 12 | $13 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $17 | $16,56513 claims |
| PfizerEliquis | $40 | $10,62919 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Albany
- Elizabeth TyeAlbany$78K
- Mary HockmanAlbany$10K
- Crystal LogsdonSavannah$566K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Pamela AllenRome$270K
- Tajuana BradleyJohns Creek$256K
- Janice McAlisterAtlanta$241K
- Jessica AdkinsSavannah$226K
- Laura ElledgeAtlanta$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.